Pathogens, Free Full-Text

Staphylococcus aureus (S. aureus) causes the vast majority of skin and soft tissue infections (SSTIs) in humans. S. aureus has become increasingly resistant to antibiotics and there is an urgent need for new strategies to tackle S. aureus infections. Vaccines offer a potential solution to this epidemic of antimicrobial resistance. However, the development of next generation efficacious anti-S. aureus vaccines necessitates a greater understanding of the protective immune response against S. aureus infection. In particular, it will be important to ascertain if distinct immune mechanisms are required to confer protection at distinct anatomical sites. Recent discoveries have highlighted that interleukin-17-producing T cells play a particularly important role in the immune response to S. aureus skin infection and suggest that vaccine strategies to specifically target these types of T cells may be beneficial in the treatment of S. aureus SSTIs. S. aureus expresses a large number of cell wall-anchored (CWA) proteins, which are covalently attached to the cell wall peptidoglycan. The virulence potential of many CWA proteins has been demonstrated in infection models; however, there is a paucity of information regarding their roles during SSTIs. In this review, we highlight potential candidate antigens for vaccines targeted at protection against SSTIs.

Study shows diverse gut bacteria communities protect against harmful pathogens by nutrient blocking

Identification of Antibiotic Resistance in ESKAPE Pathogens through Plasmonic Nanosensors and Machine Learning

Pathogens, Free Full-Text

Pathogens and Immunity

Pathogens and Immunity

Pathogens, Free Full-Text

Detection of Viable Pathogens Using Label-Free Electrical Detection of Nucleic Acid Amplification : LIBNA

Pathogens, Definition, Types & Examples - Video & Lesson Transcript

PDF) Molecular detection of tick-borne bacteria and protozoa in cervids and wild boars from Portugal

Nutritional immunity: the battle for nutrient metals at the host–pathogen interface